ArticleMembranes2022
Scale Up and Validation of Novel Tri-Bore PVDF Hollow Fiber Membranes for Membrane Distillation Application in Desalination and Industrial Wastewater Recycling.
Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Novel tri-bore polyvinylidene difluoride (PVDF) hollow fiber membranes (TBHF) were scaled-up for fabrication on industrial-scale hollow fiber spinning equipment, with the objective of validating the membrane technology for membrane distillation (MD) applications in areas such as desalination, resource recovery, and zero liquid discharge. The membrane chemistry and spinning processes were adapted from a previously reported method and optimized to suit large-scale production processes with the objective of translating the technology from lab scale to pilot scale and eventual commercialization. The membrane process was successfully optimized in small 1.5 kg batches and scaled-up to 20 kg and 50 kg batch sizes with good reproducibility of membrane properties. The membranes were then assembled into 0.5-inch and 2-inch modules of different lengths and evaluated in direct contact membrane distillation (DCMD) mode, as well as vacuum membrane distillation (VMD) mode. The 0.5-inch modules had a permeate flux >10 L m−2 h−1, whereas the 2-inch module flux dropped significantly to <2 L m−2 h−1 according to testing with 3.5 wt.% NaCl feed. Several optimization trials were carried out to improve the DCMD and VMD flux to >5 L m−2 h−1, whereas the salt rejection consistently remained ≥99.9%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.